secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2025-05-29T23:59:59+00:00
Accession:  0001193125-25-130620
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acadia shareholders elect three Class III directors, approve say-on-pay, ratify EY auditor
--------------------------------------------------------------------------------

- Elected Catherine Owen Adams, Laura A. Brege, and Elizabeth A. Garofalo, M.D. as Class III directors; each received >129M votes for.
- Advisory vote on named executive officer compensation approved: 142.2M for, 2.8M against, 108.8K abstain.
- Ernst & Young LLP ratified as independent auditor for FY2025: 154.5M for, 926.5K against, 35.0K abstain.
- Broker non-votes of 10.3M shares on director election and advisory compensation vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312525130620/0001193125-25-130620-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312525130620/d16794d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-130620

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer